Characteristics of patients with familial Mediterranean fever in Denmark: a retrospective nationwide register-based cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Characteristics of patients with familial Mediterranean fever in Denmark : a retrospective nationwide register-based cohort study. / Mortensen, S. B.; Hansen, A. E.; Lundgren, J.; Barfod, T. S.; Ambye, L.; Dunø, M.; Schade Larsen, C.; Andersen, D. C.; Jakobsen, M. A.; Johansen, I. S.

I: Scandinavian Journal of Rheumatology, Bind 49, Nr. 6, 2020, s. 1-9.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Mortensen, SB, Hansen, AE, Lundgren, J, Barfod, TS, Ambye, L, Dunø, M, Schade Larsen, C, Andersen, DC, Jakobsen, MA & Johansen, IS 2020, 'Characteristics of patients with familial Mediterranean fever in Denmark: a retrospective nationwide register-based cohort study', Scandinavian Journal of Rheumatology, bind 49, nr. 6, s. 1-9. https://doi.org/10.1080/03009742.2020.1756400

APA

Mortensen, S. B., Hansen, A. E., Lundgren, J., Barfod, T. S., Ambye, L., Dunø, M., Schade Larsen, C., Andersen, D. C., Jakobsen, M. A., & Johansen, I. S. (2020). Characteristics of patients with familial Mediterranean fever in Denmark: a retrospective nationwide register-based cohort study. Scandinavian Journal of Rheumatology, 49(6), 1-9. https://doi.org/10.1080/03009742.2020.1756400

Vancouver

Mortensen SB, Hansen AE, Lundgren J, Barfod TS, Ambye L, Dunø M o.a. Characteristics of patients with familial Mediterranean fever in Denmark: a retrospective nationwide register-based cohort study. Scandinavian Journal of Rheumatology. 2020;49(6):1-9. https://doi.org/10.1080/03009742.2020.1756400

Author

Mortensen, S. B. ; Hansen, A. E. ; Lundgren, J. ; Barfod, T. S. ; Ambye, L. ; Dunø, M. ; Schade Larsen, C. ; Andersen, D. C. ; Jakobsen, M. A. ; Johansen, I. S. / Characteristics of patients with familial Mediterranean fever in Denmark : a retrospective nationwide register-based cohort study. I: Scandinavian Journal of Rheumatology. 2020 ; Bind 49, Nr. 6. s. 1-9.

Bibtex

@article{4dc27d4fe88543f5bb3b71d6f48f0cea,
title = "Characteristics of patients with familial Mediterranean fever in Denmark: a retrospective nationwide register-based cohort study",
abstract = "Objectives: To investigate epidemiology, demography, and genetic and clinical characteristics of patients with familial Mediterranean fever (FMF) in Denmark. Method: In this population-based, cross-sectional cohort study, we identified FMF patients from discharge diagnoses using ICD-10 codes in the Danish National Patient Register, and linked data from the Danish Civil Registration System and laboratory databases for results of MEFV gene variant screening. Results: We identified 495 FMF patients (prevalence 1:11 680) with a median age of 29 years and a female ratio of 51%. The median age at diagnosis of FMF was 13 (IQR 7–22) years, with an estimated median diagnostic delay of 3 (IQR 0.7–6.9) years. The predominant ethnicities were Turkish (41.8%), Lebanese (15.8%), Syrian (6.5%), South-West Asian (7.9%), and South-East Asian (3.0%). The MEFV genotype distribution was 18.7% homozygous, 21.2% compound heterozygous, 32.0% heterozygous, 11.0% with complex alleles or unresolved zygosity, and 17.1% with no detected variants. M694V was the most prevalent variant in the overall cohort (32.5%). Homozygous or compound heterozygous MEFV exon 10 variants were associated with younger age at diagnosis (p < 0.001) and reduced number of hospital contacts before diagnosis (p = 0.008). The Charlson Comorbidity Index was ≥ 2 in 8.1% of patients. The prevalence of amyloidosis was 1.0%. Conclusions: FMF in Denmark is rare and patients are mainly of Eastern Mediterranean ethnicity. Diagnostic delay was long but patients with exon 10 MEFV variants were diagnosed at a younger age. Prolonged diagnostic delay is probably caused by lack of FMF awareness in the Danish healthcare system.",
author = "Mortensen, {S. B.} and Hansen, {A. E.} and J. Lundgren and Barfod, {T. S.} and L. Ambye and M. Dun{\o} and {Schade Larsen}, C. and Andersen, {D. C.} and Jakobsen, {M. A.} and Johansen, {I. S.}",
year = "2020",
doi = "10.1080/03009742.2020.1756400",
language = "English",
volume = "49",
pages = "1--9",
journal = "Scandinavian Journal of Rheumatology",
issn = "0300-9742",
publisher = "Taylor & Francis",
number = "6",

}

RIS

TY - JOUR

T1 - Characteristics of patients with familial Mediterranean fever in Denmark

T2 - a retrospective nationwide register-based cohort study

AU - Mortensen, S. B.

AU - Hansen, A. E.

AU - Lundgren, J.

AU - Barfod, T. S.

AU - Ambye, L.

AU - Dunø, M.

AU - Schade Larsen, C.

AU - Andersen, D. C.

AU - Jakobsen, M. A.

AU - Johansen, I. S.

PY - 2020

Y1 - 2020

N2 - Objectives: To investigate epidemiology, demography, and genetic and clinical characteristics of patients with familial Mediterranean fever (FMF) in Denmark. Method: In this population-based, cross-sectional cohort study, we identified FMF patients from discharge diagnoses using ICD-10 codes in the Danish National Patient Register, and linked data from the Danish Civil Registration System and laboratory databases for results of MEFV gene variant screening. Results: We identified 495 FMF patients (prevalence 1:11 680) with a median age of 29 years and a female ratio of 51%. The median age at diagnosis of FMF was 13 (IQR 7–22) years, with an estimated median diagnostic delay of 3 (IQR 0.7–6.9) years. The predominant ethnicities were Turkish (41.8%), Lebanese (15.8%), Syrian (6.5%), South-West Asian (7.9%), and South-East Asian (3.0%). The MEFV genotype distribution was 18.7% homozygous, 21.2% compound heterozygous, 32.0% heterozygous, 11.0% with complex alleles or unresolved zygosity, and 17.1% with no detected variants. M694V was the most prevalent variant in the overall cohort (32.5%). Homozygous or compound heterozygous MEFV exon 10 variants were associated with younger age at diagnosis (p < 0.001) and reduced number of hospital contacts before diagnosis (p = 0.008). The Charlson Comorbidity Index was ≥ 2 in 8.1% of patients. The prevalence of amyloidosis was 1.0%. Conclusions: FMF in Denmark is rare and patients are mainly of Eastern Mediterranean ethnicity. Diagnostic delay was long but patients with exon 10 MEFV variants were diagnosed at a younger age. Prolonged diagnostic delay is probably caused by lack of FMF awareness in the Danish healthcare system.

AB - Objectives: To investigate epidemiology, demography, and genetic and clinical characteristics of patients with familial Mediterranean fever (FMF) in Denmark. Method: In this population-based, cross-sectional cohort study, we identified FMF patients from discharge diagnoses using ICD-10 codes in the Danish National Patient Register, and linked data from the Danish Civil Registration System and laboratory databases for results of MEFV gene variant screening. Results: We identified 495 FMF patients (prevalence 1:11 680) with a median age of 29 years and a female ratio of 51%. The median age at diagnosis of FMF was 13 (IQR 7–22) years, with an estimated median diagnostic delay of 3 (IQR 0.7–6.9) years. The predominant ethnicities were Turkish (41.8%), Lebanese (15.8%), Syrian (6.5%), South-West Asian (7.9%), and South-East Asian (3.0%). The MEFV genotype distribution was 18.7% homozygous, 21.2% compound heterozygous, 32.0% heterozygous, 11.0% with complex alleles or unresolved zygosity, and 17.1% with no detected variants. M694V was the most prevalent variant in the overall cohort (32.5%). Homozygous or compound heterozygous MEFV exon 10 variants were associated with younger age at diagnosis (p < 0.001) and reduced number of hospital contacts before diagnosis (p = 0.008). The Charlson Comorbidity Index was ≥ 2 in 8.1% of patients. The prevalence of amyloidosis was 1.0%. Conclusions: FMF in Denmark is rare and patients are mainly of Eastern Mediterranean ethnicity. Diagnostic delay was long but patients with exon 10 MEFV variants were diagnosed at a younger age. Prolonged diagnostic delay is probably caused by lack of FMF awareness in the Danish healthcare system.

U2 - 10.1080/03009742.2020.1756400

DO - 10.1080/03009742.2020.1756400

M3 - Journal article

C2 - 32608308

AN - SCOPUS:85087790512

VL - 49

SP - 1

EP - 9

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

SN - 0300-9742

IS - 6

ER -

ID: 258323350